---

Levofloxacin and Thrombocytopenia

Note on terminology: "Levofloxacillin" is not a real drug. The correct name is levofloxacin (Levaquin), a third-generation fluoroquinolone antibiotic. The "-cillin" suffix belongs to penicillin-class drugs.

---

Overview

1. Drug-Induced Immune Thrombocytopenia (DIIT) - the more common mechanism
2. Drug-Induced Thrombotic Thrombocytopenic Purpura (TTP) - rarer but more severe

---

1. Drug-Induced Immune Thrombocytopenia (DIIT)

• The drug binds to platelet surface glycoproteins (particularly GPIIb/IIIa) and acts as a hapten or conformational inducer.
• Drug-dependent antibodies (typically IgG) form and bind to this drug-platelet complex.
• Immune-mediated platelet destruction leads to peripheral thrombocytopenia.
• In vitro analysis shows anti-glycoprotein IIb/IIIa IgG with increased binding affinity in the presence of soluble fluoroquinolone molecules.

• Onset typically within days of starting the drug (a published case report describes severe thrombocytopenia after just 4 days of oral levofloxacin)
• Can occur on first exposure (no prior sensitization required in some cases)
• May present with hemoptysis, petechiae, ecchymosis, or mucosal bleeding
• Platelet counts can drop dramatically (severe thrombocytopenia)
• Patients previously tolerant of ciprofloxacin may still develop levofloxacin-induced thrombocytopenia - cross-reactivity between fluoroquinolones is not guaranteed

• Stop levofloxacin immediately - this is the single most important step
• Switch to an alternative antibiotic from a different class (e.g., cefepime, beta-lactams)
• Platelet count typically recovers within days to weeks after discontinuation
• Monitor CBC closely; transfuse platelets only if life-threatening bleeding occurs

---

2. Drug-Induced TTP (Thrombotic Thrombocytopenic Purpura)

• Triggered by autoantibody formation against ADAMTS-13 (von Willebrand factor-cleaving protease), or by direct microvascular endothelial cell injury.
• Without ADAMTS-13 function, large vWF multimers accumulate, leading to platelet microthrombi throughout the microvasculature.
• Results in the classic TTP pentad: microangiopathic hemolytic anemia, thrombocytopenia, neurologic abnormalities, renal impairment, fever

• Discontinue levofloxacin immediately
• Daily plasmapheresis (40 mL/kg or 1.0-1.5x plasma volume) - effective in >80% of cases
• Fresh frozen plasma if plasmapheresis cannot be started promptly
• Avoid platelet transfusions (can worsen thrombosis, cause renal failure, and death) unless life-threatening bleeding or intracranial hemorrhage
• Steroids, rituximab, cyclosporine may be added in autoimmune TTP
• Heparin is NOT beneficial in TTP

---

Clinical Bottom Line

---

• Tintinalli's Emergency Medicine: A Comprehensive Study Guide - levofloxacin listed among drugs causing TTP via ADAMTS-13/microangiopathic mechanism
• PMC4738914 (Probable Levofloxacin-Induced Thrombocytopenia, Case Report + Literature Review) - GPIIb/IIIa antibody mechanism, ciprofloxacin structural similarity to quinine
• Polprasert & Prayongratana, JMAT - case of severe thrombocytopenia after 4 days of levofloxacin, first exposure, anti-GPIIb/IIIa antibody mechanism

---

Drugs Causing Thrombocytopenia

---

Mechanisms of Drug-Induced Thrombocytopenia

1. Immune-Mediated (Most Common)

Quinine is the classic prototype. Even quinine in tonic water can trigger severe, life-threatening thrombocytopenia ("gin and tonic purpura") - the reaction is not dose-dependent.

2. Heparin-Induced Thrombocytopenia (HIT) - Special Category

• UFH carries higher HIT risk than LMWH
• Fondaparinux: virtually no HIT risk
• Once Type II HIT develops, even LMWH must be avoided

3. Myelosuppression (Decreased Production)

• Cytotoxic chemotherapy (most agents)
• Radiation therapy
• Ethanol (chronic use)
• Ganciclovir, valganciclovir
• Linezolid (with prolonged use)
• Chloramphenicol

4. TTP (Thrombotic Microangiopathy)

• Fluoroquinolones: ciprofloxacin, ofloxacin, levofloxacin
• Quinine
• Clopidogrel, ticlopidine
• Cyclosporine, sirolimus (especially in combination)
• Mitomycin
• Valacyclovir
• Risperidone, lansoprazole, infliximab

---

Drugs Strongly Associated with Thrombocytopenia (by class)

Antibiotics and Antivirals

Cardiovascular Drugs

Neurological / Psychiatric

Oncology / Immunology

GI / Other

---

DIIT vs. ITP: Key Distinguishing Features

---

General Management

1. Stop all suspected offending drugs - single most important step
2. Platelet count typically recovers within days to 1 week after stopping (longer for drugs with long half-lives)
3. Platelet transfusion if platelets <10,000-15,000/μL or active bleeding
4. If ITP cannot be excluded and thrombocytopenia is life-threatening: consider corticosteroids or IVIG
5. For HIT: immediately stop ALL heparin forms; start a direct thrombin inhibitor (argatroban, bivalirudin) or fondaparinux; avoid warfarin until platelets recover; avoid platelet transfusions
6. For drug-TTP: stop offending drug + plasma exchange; avoid platelet transfusions

Important exception: Unlike most DIT (which causes bleeding), HIT causes thrombosis - platelet transfusions in HIT are relatively contraindicated as they can fuel further clot formation.

---

• Goldman-Cecil Medicine, International Edition - Table 158-3 and drug-induced thrombocytopenia section
• Robbins, Cotran & Kumar Pathologic Basis of Disease - GPIIb/IIIa conformational change mechanism, HIT pathophysiology
• Rosen's Emergency Medicine - "innocent bystander" mechanism, HIT 4Ts scoring
• Henry's Clinical Diagnosis and Management by Laboratory Methods - drug-dependent vs. drug-independent antibodies